SYSTEMIC BEVACIZUMAB (AVASTIN) FOR JUVENILE-ONSET RECURRENT RESPIRATORY PAPILLOMATOSIS: A SYSTEMATIC REVIEW
Article Sidebar
Main Article Content
Abstract
The article devoted to open the theme systemic bevacizumab (avastin) for juvenile-onset recurrent respiratory papillomatosis: a systematic review. Moreover, it deals with the important data about cause and treatment of the illness.
Article Details
References
REFERENCES:
Vargas SO, Healy GB, Rahbar R, Folkman J, Tan X, McGill TJ, et al. (2005) Role of vascular endothelial growth factor-a in recurrent respiratory papillomatosis. Ann Otol Rhinol Laryngol. 114(4):289–295. Available from: https://pubmed.ncbi.nlm.nih.gov/15895784
Schroff S, Derkay CS, Burke B, Lawson L. (2004) American Society of Pediatric Otolaryngology members’ experience with recurrent respiratory papillomatosis and the use of adjuvant therapy. Arch Otolaryngol Head Neck Surg 130(9):1039–42. Available from: https://pubmed.ncbi.nlm.nih.gov/15381589/
Drejet S, Halum S, Brigger M, Skopelja E, Parker NP. (2017) A systematic review: outcomes in adult recurrent respiratory papillomatosis treated with intralesional cidofovir or bevacizumab. Otolaryngol Head Neck Surg (United States). 6(3):435–41. Available from: http://journals.sagepub.com/doi/10.1177/0194599816683384
Rahbar R, Vargas SO, Folkman J, McGill TJ, Healy GB, et al. (2005) Role of vascular endothelial growth factor-A in recurrent respiratory papillomatosis. Ann Otol Rhinol Laryngol 114: 289-295. [Crossref]
Mohr M, Schliemann C, Biermann C, Schmidt LH, Kessler T, et al. (2014) Rapid response to systemic bevacizumab therapy in recurrent respiratory papillomatosis. Oncol Lett 8: 1912-1918. [Crossref]
Sidell DR, Nassar M, Cotton RT, Zeitels SM, de Alarcon A (2014) High-dose sublesional bevacizumab (avastin) for pediatric recurrent respiratory papillomatosis. Ann Otol Rhinol Laryngol 123: 214-221. [Crossref]
Zeitels SM, Barbu AM, Landau-Zemer T, Lopez-Guerra G, Burns JA, Friedman AD, et al. (2011) Local Injection of bevacizunab(Avastin) and angiolytic KTP laser treatment of reccurent respiratory papillomatosis of vocal folds: a prospective study. Ann Otol Rhinol Laryngol 120: 627-634. [Crossref]
Rogers DJ, Ojha S, Maurer R, Hartnick CJ (2013) Use of adjuvant intralesional bevacizumab for aggressive respiratory papillomatosis in children. JAMA Otolaryngol Head Neck Surg 139: 496-501. [Crossref]
Maturo S, Hartnick CJ (2010) Use of 532-nm pulsed potassium titanyl phosphate laser and adjuvant intralesional bevacizumab for aggressive respiratory papillomatosis in children: initial experience. Arch Otolaryngol Head Neck Surg 136: 561-565. [Crossref]